So, can chemistry students make a difference in medicine?
Cui, a Chinese-American female scientist, led a team in Pfizer, USA, and won the 38th National Invention Award for inventing a drug for treating lung cancer. Since then, she also led the team to develop three generations of clotinib series anticancer drugs. For ALk mutation, a considerable proportion of patients with advanced lung cancer have this mutation that can be stably controlled for several years.
Cui 1980 was admitted to the Department of Applied Chemistry of Chinese University of Science and Technology from the Middle School Attached to Shaanxi Normal University in An. Her great achievements in the research and development of new drugs for lung cancer have attracted the attention of many American websites. According to the website of TPI (Biomedical Trends), when reporting the news that the drug passed the US Food and Drug Administration (FDA), she used half of the space to introduce Dr. Cui Jingrong, the first inventor of the new drug, and called Cui Jingrong the first author of the patent of crizotinib and the first author of a recent paper introducing the molecular design of Xalkori drug. The news introduced the background of Cui, a female scientist in China, in great detail, and pointed out that "1985 and 1988 received a bachelor's degree and a master's degree respectively." Later, she received her Ph.D. from Ohio State University and went to Lawrence Berkeley National Laboratory for postdoctoral research.
The world's leading medicine, the medicine that has saved countless lives, is a great female scientist in China.